U-CORT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover U-cort, and when can generic versions of U-cort launch?
U-cort is a drug marketed by Taro and is included in one NDA.
The generic ingredient in U-CORT is hydrocortisone acetate. There are sixty-seven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the hydrocortisone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for U-CORT?
- What are the global sales for U-CORT?
- What is Average Wholesale Price for U-CORT?
Summary for U-CORT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| DailyMed Link: | U-CORT at DailyMed |
Pharmacology for U-CORT
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for U-CORT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro | U-CORT | hydrocortisone acetate | CREAM;TOPICAL | 089472-001 | Jun 13, 1988 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
